Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study-Reference-Cited by-同舟云学术

Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study

Published:2002-02 Issue:9305 Volume:359 Page:481-486
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Hofmann Wolf-K,de Vos Sven,Elashoff David,Gschaidmeier Harald,Hoelzer Dieter,Koeffler H Phillip,Ottmann Oliver G

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome;Druker;N Engl J Med,2001

2. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001

3. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias;Honda;Blood,1998

4. Reversibility of acute B-cell leukaemia induced by BCR-ABL1;Huettner;Nat Genet,2000

5. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells;Druker;Nat Med,1996

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Field cancerization profile-based prognosis signatures lead to more robust risk evaluation in hepatocellular carcinoma;iScience;2022-02

2. Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models;International Journal of Molecular Sciences;2020-10-12

3. Huaier extract enhances the treatment efficacy of imatinib in Ik6+ Ph+ acute lymphoblastic leukemia;Biomedicine & Pharmacotherapy;2019-09

4. How does the novel T315L mutation of breakpoint cluster region-abelson (BCR-ABL) kinase confer resistance to ponatinib: a comparative molecular dynamics simulation study;Journal of Biomolecular Structure and Dynamics;2019-02-05

5. Cardiac Function Improvement and Bone Marrow Response –;EBioMedicine;2017-08